Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Joost Kools"'
Autor:
Joost Kools, Nicol Voermans, Karlien Mul, John Jiang, Jennifer Shoskes, Kelly Marshall, Markus Karlsson
Publikováno v:
Monday, April 24.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3ae063b442499e2c69efbb7e9c0e03d3
https://doi.org/10.1212/wnl.0000000000203580
https://doi.org/10.1212/wnl.0000000000203580
Autor:
Joost Kools, Nicol Voermans, Karlien Mul, John Jiang, Jennifer Shoskes, Kelly Marshall, Anil Tarachandani, Joanita Figueredo, Damien Eggenspieler
Publikováno v:
Sunday, April 23.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::759476ecad4267369fce781906b3209b
https://doi.org/10.1212/wnl.0000000000203553
https://doi.org/10.1212/wnl.0000000000203553
Autor:
Michelle L. Mellion, Per Widholm, Markus Karlsson, André Ahlgren, Rabi Tawil, Kathryn R. Wagner, Jeffrey M. Statland, Leo Wang, Perry B. Shieh, Baziel G.M. van Engelen, Joost Kools, Lucienne Ronco, Adefowope Odueyungbo, John Jiang, Jay J. Han, Maya Hatch, Jeanette Towles, Olof Dahlqvist Leinhard, Diego Cadavid
Publikováno v:
Neurology, 99, E877-E889
Neurology, 99, 9, pp. E877-E889
Neurology, 99, 9, pp. E877-E889
Background and ObjectivesFacioscapulohumeral muscular dystrophy (FSHD) is a rare, debilitating disease characterized by progressive muscle weakness. MRI is a sensitive assessment of disease severity and progression. We developed a quantitative whole-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::682af05da5705ffb348de48a46859ace
https://doi.org/10.1212/wnl.0000000000200757
https://doi.org/10.1212/wnl.0000000000200757
Autor:
Joost Kools, Willem Aerts, Erik H. Niks, Karlien Mul, Lisa Pagan, Jake S.F. Maurits, Renée Thewissen, Baziel G. van Engelen, Nicol C. Voermans
Publikováno v:
Neuromuscular Disorders, 33, 440-446
Neuromuscular Disorders, 33, 5, pp. 440-446
Neuromuscular Disorders, 33, 5, pp. 440-446
Contains fulltext : 293215.pdf (Publisher’s version ) (Open Access) Muscle biopsies are used in clinical trials to measure target engagement of the investigational product. With many upcoming therapies for patients with facioscapulohumeral dystroph
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::270f7e1f0476b0817054e58bdca93f5f
https://hdl.handle.net/https://repository.ubn.ru.nl/handle/2066/293215
https://hdl.handle.net/https://repository.ubn.ru.nl/handle/2066/293215
